{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:09:02Z","timestamp":1791929342871,"version":"4.3.4"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2012,7,13]],"date-time":"2012-07-13T00:00:00Z","timestamp":1342137600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0039783","type":"journal-article","created":{"date-parts":[[2012,7,14]],"date-time":"2012-07-14T05:04:00Z","timestamp":1342242240000},"page":"e39783","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":49,"title":["Hepcidin-25 in Chronic Hemodialysis Patients Is Related to Residual Kidney Function and Not to Treatment with Erythropoiesis Stimulating Agents"],"prefix":"10.1371","volume":"7","author":[{"given":"Neelke C.","family":"van der Weerd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel P. C.","family":"Grooteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel L.","family":"Bots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinus A.","family":"van den Dorpel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire H.","family":"den Hoedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert H. A.","family":"Mazairac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menso J.","family":"Nub\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Lars","family":"Penne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo A.","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack F. M.","family":"Wetzels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin T.","family":"Wiegerinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorine W.","family":"Swinkels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Blankestijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet M. ter","family":"Wee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"CONTRAST investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,7,13]]},"reference":[{"key":"ref1","first-page":"726","article-title":"Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD.","volume":"55","author":"JL Babitt","year":"2010","journal-title":"AmJKidney Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1373\/clinchem.2009.140053","article-title":"Hepcidin in human iron disorders: diagnostic implications.","volume":"57","author":"JJ Kroot","year":"2011","journal-title":"Clin Chem"},{"key":"ref3","first-page":"1681","article-title":"Current status of the measurement of blood hepcidin levels in chronic kidney disease.","volume":"5","author":"IC Macdougall","year":"2010","journal-title":"ClinJAmSocNephrol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ki.2011.141","article-title":"Hepcidin: clinical utility as a diagnostic tool and therapeutic target.","volume":"80","author":"DW Coyne","year":"2011","journal-title":"Kidney Int"},{"key":"ref5","first-page":"848","article-title":"Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate.","volume":"25","author":"HPE Peters","year":"2010","journal-title":"NephrolDialTransplant"},{"key":"ref6","first-page":"1051","article-title":"Hepcidin\u2013a potential novel biomarker for iron status in chronic kidney disease.","volume":"4","author":"J Zaritsky","year":"2009","journal-title":"ClinJAmSocNephrol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000253590","article-title":"Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in haemodialysis patients.","volume":"122","author":"E Costa","year":"2009","journal-title":"Acta Haematol"},{"key":"ref8","first-page":"2450","article-title":"Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease?","volume":"23","author":"DW Swinkels","year":"2008","journal-title":"NephrolDialTransplant"},{"key":"ref9","first-page":"943","article-title":"Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease\/chronic heart failure patients.","volume":"12","author":"K van der Putten","year":"2010","journal-title":"EurJHeart Fail"},{"key":"ref10","first-page":"S4","article-title":"Assessing iron status: beyond serum ferritin and transferrin saturation.","volume":"1","author":"JB Wish","year":"2006","journal-title":"ClinJAmSocNephrol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/ki.2009.21","article-title":"Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease.","volume":"75","author":"DR Ashby","year":"2009","journal-title":"Kidney Int"},{"key":"ref12","first-page":"115","article-title":"Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients.","volume":"28","author":"A Kato","year":"2008","journal-title":"AmJNephrol"},{"key":"ref13","first-page":"534","article-title":"Determinants of hepcidin in patients on maintenance hemodialysis: role of inflammation.","volume":"31","author":"T Kuragano","year":"2010","journal-title":"AmJNephrol"},{"key":"ref14","first-page":"883","article-title":"Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy.","volume":"39","author":"G Weiss","year":"2009","journal-title":"EurJClinInvest"},{"key":"ref15","first-page":"1010","article-title":"Reduction of serum hepcidin by hemodialysis in pediatric and adult patients.","volume":"5","author":"J Zaritsky","year":"2010","journal-title":"ClinJAmSocNephrol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3109\/08860220903216071","article-title":"Type of renal replacement therapy and residual renal function may affect prohepcidin and hepcidin.","volume":"31","author":"J Malyszko","year":"2009","journal-title":"Ren Fail"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1373\/clinchem.2010.149187","article-title":"Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders.","volume":"56","author":"JJ Kroot","year":"2010","journal-title":"Clin Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.3324\/haematol.2009.010322","article-title":"Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization.","volume":"94","author":"JJ Kroot","year":"2009","journal-title":"Haematologica"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1468-6708-6-8","article-title":"Effect of increased convective clearance by on-line hemodiafiltration on all cause and cardiovascular mortality in chronic hemodialysis patients - the Dutch CONvective TRAnsport STudy (CONTRAST): rationale and design of a randomised controlled trial [ISRCTN38365125].","volume":"6","author":"EL Penne","year":"2005","journal-title":"CurrControl Trials CardiovascMed"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1681\/ASN.2011121140","article-title":"Effect of Online Hemodiafiltration on All-Cause Mortality and Cardiovascular Outcomes.","volume":"23","author":"MP Grooteman","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"ref21","first-page":"ii1","article-title":"Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure.","volume":"19","author":"F Locatelli","year":"2004","journal-title":"NephrolDialTransplant"},{"key":"ref22","first-page":"S182","article-title":"IV. NKF-K\/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000.","volume":"37","year":"2001","journal-title":"AmJKidney Dis"},{"key":"ref23","first-page":"S11","article-title":"KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease.","volume":"47","year":"2006","journal-title":"AmJKidney Dis"},{"key":"ref24","first-page":"471","article-title":"KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target.","volume":"50","year":"2007","journal-title":"AmJKidney Dis"},{"key":"ref25","first-page":"2408","article-title":"The relation between chemically measured total iron-binding capacity concentrations and immunologically measured transferrin concentrations in human serum.","volume":"43","author":"R Gambino","year":"1997","journal-title":"ClinChem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e2706","DOI":"10.1371\/journal.pone.0002706","article-title":"Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry.","volume":"3","author":"DW Swinkels","year":"2008","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1373\/clinchem.2006.079186","article-title":"Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications.","volume":"53","author":"EH Kemna","year":"2007","journal-title":"Clin Chem"},{"key":"ref28","first-page":"ii45","article-title":"EBPG guideline on nutrition.","volume":"22","author":"D Fouque","year":"2007","journal-title":"NephrolDialTransplant"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1182\/blood-2011-02-337907","article-title":"Serum hepcidin: reference ranges and biochemical correlates in the general population.","volume":"117","author":"TE Galesloot","year":"2011","journal-title":"Blood"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5414\/CNP58363","article-title":"Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients.","volume":"58","author":"WC Chiang","year":"2002","journal-title":"Clin Nephrol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/ndt\/17.6.1063","article-title":"Determinants of circulating soluble transferrin receptor level in chronic haemodialysis patients.","volume":"17","author":"DC Tarng","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/sj.ki.5002223","article-title":"Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturation.","volume":"71","author":"AK Singh","year":"2007","journal-title":"Kidney Int"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/ki.2010.254","article-title":"Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients.","volume":"78","author":"BA Ford","year":"2010","journal-title":"Kidney Int"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"10289","DOI":"10.1073\/pnas.0603124103","article-title":"Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6.","volume":"103","author":"J Truksa","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/ndt\/gfr431","article-title":"Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study.","volume":"27","author":"T Uehata","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.diabres.2011.03.028","article-title":"Hepcidin expression and iron parameters change in Type 2 diabetic patients.","volume":"93","author":"F Jiang","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000235747","article-title":"Serum prohepcidin and hepcidin in hemodialyzed patients undergoing iron therapy.","volume":"32","author":"J Malyszko","year":"2009","journal-title":"Kidney Blood Press Res"},{"key":"ref38","first-page":"3996","article-title":"Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents.","volume":"25","author":"N Tessitore","year":"2010","journal-title":"NephrolDialTransplant"},{"key":"ref39","first-page":"329646","article-title":"Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS.","volume":"2010","author":"N Campostrini","year":"2010","journal-title":"JBiomedBiotechnol"},{"key":"ref40","doi-asserted-by":"crossref","DOI":"10.1038\/ki.2009.272","article-title":"The utility of multivariate analysis in the study of hepcidin.","author":"JJ Zaritsky","year":"2009"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0039783","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T08:31:43Z","timestamp":1540369903000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0039783"}},"subtitle":[],"editor":[{"given":"Leighton R.","family":"James","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,7,13]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2012,7,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0039783","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,13]]}}}